Chr. Hansen A/s

Birgitte Stuer-Lauridsen

Eric Johansen

Patrick Derkx

Beatrice Nielsen

Thomas Janzen

Iben Jeppesen

Mette Dines Cantor

Susanne Abrahamsen

Peter Wagner

Lasse Vigel Joergensen

Astrain characterized by (i): sensitivity for ampicillin, vancomycin, gentamicin, kanamycin, streptomycin, erythromycin, clindamycin, tetracycline and chloramphenicol antimicrobial activity againstand; and (iii) a sporulation percentage of at least 80 when measured after 2 days of incubation. The invention further relates to a method for selecting such strains. Many of the identified strains according to the invention are of the species. Some of thewere further identified assubsp.whereas others were identified assubsp.. Astrain of the invention may be used as a feed additive to animal feed where it has a probiotic effect.

Antibiotic sensitivestrains having antimicrobial effect againstandand having high sporulation capacity

Astrain characterized by (i): sensitivity for ampicillin, vancomycin, gentamicin, kanamycin, streptomycin, erythromycin, clindamycin, tetracycline and chloramphenicol; (ii) antimicrobial activity againstand; and (iii) a sporulation percentage of at least 80 when measured after 2 days of incubation. The invention further relates to a method for selecting such strains. Many of the identified strains according to the invention are of the species. Some of thewere further identified assubsp.whereas others were identified assubsp.. Astrain of the invention may be used as a feed additive to animal feed where it has a probiotic effect.

[object Object]

A lactic acid bacterium (LAB) wherein an YjaE protein is essentially inactive and the LAB thereby get improved resistance to bacteriophages, a starter culture composition comprising the lactic acid bacterium and use of this starter culture manufacturing a food or feed product.

Bacteriophage resistant lactic acid bacteria

Growing community of inventors

Virum, Denmark

Birgitte Stuer-Lauridsen